Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Capital Leases (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Capital Leases for 15 consecutive years, with $22000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Capital Leases fell 66.15% to $22000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $22000.0, a 66.15% decrease, with the full-year FY2024 number at $47000.0, down 59.48% from a year prior.
  • Capital Leases was $22000.0 for Q3 2025 at Xtant Medical Holdings, down from $30000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $213000.0 in Q2 2022 to a low of $22000.0 in Q3 2025.
  • A 5-year average of $110210.5 and a median of $111000.0 in 2021 define the central range for Capital Leases.
  • Peak YoY movement for Capital Leases: surged 80.51% in 2022, then tumbled 66.15% in 2025.
  • Xtant Medical Holdings' Capital Leases stood at $103000.0 in 2021, then surged by 75.73% to $181000.0 in 2022, then tumbled by 35.91% to $116000.0 in 2023, then tumbled by 59.48% to $47000.0 in 2024, then plummeted by 53.19% to $22000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Capital Leases are $22000.0 (Q3 2025), $30000.0 (Q2 2025), and $39000.0 (Q1 2025).